Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Childhood Brain Tumors: Molecular Marker to Facilitate Prognosis and Treatment Planning

06.12.2005


Valuable results for the complex jigsaw puzzle of cancer development



CDK6 is the plain name of a molecule that is often characteristically altered in medulloblastoma. This type of cancer is among the most common malignant brain tumors in children. Heidelberg molecular geneticians of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found out that CDK6 can serve as an important indicator to help physicians determine the prognosis of patients. The results obtained in a project of the National Genome Research Network within the Brain Tumor Network have been published in the latest issue of the Journal of Clinical Oncology.

The typical age at the onset of medulloblastoma is seven years. Frequently, the tumor has already spread to other parts of the body. Despite intensive treatment almost half of the young patients die of this cancer. To be able to evaluate the course of such a tumor disease based on characteristic molecular markers and to develop novel treatment strategies, cancer researchers are trying to elucidate the development of the disease.


Frank Mendrzyk and Dr. Bernhard Radlwimmer of the Molecular Genetics Division have now contributed an important puzzle piece. The two researchers used the matrix-CGH technology developed by their divisional head Professor Peter Lichter to identify genetic alterations in medulloblastoma. Working with tissue samples of brain tumors they started by searching the whole genome for overrepresented and underrepresented segments of genetic material. Then they used immunological detection methods to investigate how identified candidate genes of these regions and their products are interconnected with the stage and course of the disease. This study was based on tumor tissue obtained from more than 200 patients whose medical records are known. The investigators found out that an increased number of gene copies is associated with overproduction of CDK6 and an unfavorable course of the disease. The gene located on chromosome 7 appears to play a key role in signaling pathways influencing growth and differentiation of medulloblastoma cells and other tumor cells. Compared to previously available markers, CDK6 seems to be an independent and at the same time more reliable source of information. Moreover, the gene product is easy to detect with immunological methods that are already established in routine diagnostics. CDK6 is also useful in clinical trials when it comes to evaluating the response to a treatment strategy.

The molecular geneticians have even more valuable findings to present. A factor called PPM1D is typically overproduced in medulloblastoma due to amplification of DNA segments on chromosome 17. The gene is not unknown to scientists. It is also found in multiple copies in neuroblastoma as well as in breast and ovarian cancer. Earlier publications have presented evidence suggesting that these alterations of the genetic information play a role in cancer development. Thus, other scientists showed in mouse embryonic cells that PPM1D is capable of abrogating the function of tumor suppressor gene TP53. TP53, jointly with other genes, regulates cell multiplication and thus reduces the likelihood of a cell turning into a tumor cell. Conversely, cells were resistant to transformation when they lacked PPM1D.

Further analyses and functional studies need to be performed in order to understand the exact role these genes play in the development of medulloblastoma. Eventually, cancer researchers are hoping to use this knowledge to find new targets for therapies and thus positively influence the course of the disease.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF).

Julia Rautenstrauch | alfa
Further information:
http://www.dkfz.de/en/genetics/index.html

More articles from Life Sciences:

nachricht Programming cells with computer-like logic
27.07.2017 | Wyss Institute for Biologically Inspired Engineering at Harvard

nachricht Identified the component that allows a lethal bacteria to spread resistance to antibiotics
27.07.2017 | Institute for Research in Biomedicine (IRB Barcelona)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Physicists Design Ultrafocused Pulses

Physicists working with researcher Oriol Romero-Isart devised a new simple scheme to theoretically generate arbitrarily short and focused electromagnetic fields. This new tool could be used for precise sensing and in microscopy.

Microwaves, heat radiation, light and X-radiation are examples for electromagnetic waves. Many applications require to focus the electromagnetic fields to...

Im Focus: Carbon Nanotubes Turn Electrical Current into Light-emitting Quasi-particles

Strong light-matter coupling in these semiconducting tubes may hold the key to electrically pumped lasers

Light-matter quasi-particles can be generated electrically in semiconducting carbon nanotubes. Material scientists and physicists from Heidelberg University...

Im Focus: Flexible proximity sensor creates smart surfaces

Fraunhofer IPA has developed a proximity sensor made from silicone and carbon nanotubes (CNT) which detects objects and determines their position. The materials and printing process used mean that the sensor is extremely flexible, economical and can be used for large surfaces. Industry and research partners can use and further develop this innovation straight away.

At first glance, the proximity sensor appears to be nothing special: a thin, elastic layer of silicone onto which black square surfaces are printed, but these...

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

 
Latest News

Programming cells with computer-like logic

27.07.2017 | Life Sciences

Identified the component that allows a lethal bacteria to spread resistance to antibiotics

27.07.2017 | Life Sciences

Malaria Already Endemic in the Mediterranean by the Roman Period

27.07.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>